Historical record - last NADAC publication: 8/18/2021
Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.0496 per EA under NDC 53746010205. Its NADAC has been published 404 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746010205
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
8/18/2021
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA078428On Market Since
11/24/2009
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 404 times since Nov 28, 2013, and over the history we have for it it has declined 12.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0496 per EA |
|---|---|
| All-time high | $0.0676 (Feb 12, 2014) |
| All-time low | $0.0396 (Apr 19, 2017) |
| Median price | $0.0499 |
| Average price | $0.0493 |
| Largest weekly change | +18.3% (Jan 22, 2014) |
| Weeks tracked | 404 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.0496 per EA (NDC 53746010205), effective Aug 18, 2021.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 12.0%. It has been tracked across 404 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0396 (Apr 19, 2017) to a high of $0.0676 (Feb 12, 2014), with a median of $0.0499 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
Yes. 17 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 300 MG CAPSULE, is $0.0324 per EA — about 35% below GABAPENTIN 300 MG CAPSULE.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 53746010205) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification